Immediate Impact
2 from Science/Nature 62 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Cancer stem cells and niches: challenges in immunotherapy resistance
2025 Standout
Works of Yu-Chih Wu being referenced
DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
2019
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yu-Chih Wu | 343 | 194 | 66 | 141 | 22 | 715 | |
| Hyung‐Bae Moon | 346 | 128 | 88 | 96 | 25 | 787 | |
| Sallouha Gabbouj | 339 | 178 | 131 | 191 | 35 | 773 | |
| Yonggang Lv | 218 | 137 | 169 | 200 | 27 | 627 | |
| Yu Cheng | 171 | 63 | 210 | 183 | 22 | 599 | |
| Fen Ning | 350 | 119 | 341 | 228 | 31 | 826 | |
| Ilaria Laface | 254 | 64 | 73 | 66 | 16 | 633 | |
| Gordon Stamp | 170 | 83 | 56 | 210 | 24 | 709 | |
| Yunzhong Nie | 278 | 132 | 160 | 169 | 22 | 741 | |
| Kenichi Taguchi | 231 | 104 | 75 | 214 | 18 | 684 | |
| Agnieszka Adamek | 294 | 143 | 55 | 101 | 32 | 732 |
All Works
Login with ORCID to disown or claim papers
Loading papers...